Design and methodological considerations in the National Cooperative Gallstone Study: a multicenter clinical trial.

[1]  J. Lachin.  Introduction to sample size determination and power analysis for clinical trials. , 1981, Controlled clinical trials.

[2]  R. Temple,et al.  Adverse effects of newly marketed drugs. , 1979, The New England journal of medicine.

[3]  G. Croke,et al.  Recruitment for the National Cooperative Gallstone Study , 1979, Clinical pharmacology and therapeutics.

[4]  R. A. Keller,et al.  Computerized system for the measurement of gallstone volume, in vivo. , 1979, Medical physics.

[5]  S. Grundy,et al.  Risk factors for the development of cholelithiasis in man (second of two parts). , 1978, The New England journal of medicine.

[6]  G. Bonorris,et al.  Gallstone dissolution by chenodeoxycholic acid and phenobarbital. , 1978, The American journal of gastroenterology.

[7]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .

[8]  J. Lachin.  Sample size determinants for r X c comparative trials. , 1977, Biometrics.

[9]  M. Lancaster,et al.  Influence of primary bile acid feeding on cholesterol metabolism and hepatic function in the rhesus monkey. , 1975, Mayo Clinic proceedings.

[10]  J. Thistle,et al.  Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. , 1973, The New England journal of medicine.

[11]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[12]  J. Thistle,et al.  Dissolution of cholesterol gallstones by chenodeoxycholic acid. , 1972, The New England journal of medicine.

[13]  J. Thistle,et al.  Induced alterations in composition of bile of persons having cholelithiasis. , 1971, Gastroenterology.

[14]  P. Bennett,et al.  Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. , 1970, The New England journal of medicine.

[15]  J. Farrar,et al.  Diminished bile acid pool size in patients with gallstones. , 1970, Gastroenterology.

[16]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data , 1969 .

[17]  F. Ingelfinger.  Digestive disease as a national problem. V. Gallstones. , 1968, Gastroenterology.

[18]  W. Kannel,et al.  The epidemiology of gallbladder disease: observations in the Framingham Study. , 1966, Journal of chronic diseases.

[19]  Charles W. Dunnett,et al.  New tables for multiple comparisons with a control. , 1964 .

[20]  Peter Armitage,et al.  Sequential Medical Trials , 1961, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[21]  W. Cole,et al.  Disappearance of stone shadows in postoperative cholangiograms. , 1957, Journal of the American Medical Association.

[22]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[23]  J. Rautureau,et al.  Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study. , 1977, Digestion.